Preparation of Recombinant α-Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin
スポンサーリンク
概要
- 論文の詳細を見る
We have established a large-scale manufacturing system to produce recombinant human α-thrombin. In this system, a high yield of α-thrombin is prepared from prethrombin-2 activated by recombinant ecarin. We produced human prethrombin-2 using mouse myeloma cells and an expression plasmid carrying the chicken β-actin promoter and mutant dihydrofolate reductase gene for gene amplification. To increase prethrombin-2 expression further, we performed fed-batch cultivation with the addition of vegetable peptone in 50 liters of suspension culture. After five feedings of vegetable peptone, the expression level of the recombinant prethrombin-2 reached 200 μg/ml. Subsequently, the recombinant prethrombin-2 could be activated to α-thrombin by recombinant ecarin expressed in a similar manner. Finally, recombinant α-thrombin was purified to homogeneity by affinity chromatography using a benzamidine-Sepharose gel. The yield from prethrombin-2 in culture medium was approximately 70%. The activity of the purified recombinant α-thrombin, including hydrolysis of a chromogenic substrate, release of fibrinopeptide A, and activation of protein C, was indistinguishable from that of plasma-derived α-thrombin. Our system is suitable for the large-scale production of recombinant α-thrombin, which can be used in place of clinically available α-thrombin derived from human or bovine plasma.
- 社団法人 日本生化学会の論文
著者
-
MORIKAWA Wataru
Applied Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
-
NAKATAKE Hiroshi
First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
-
NAKAGAKI Tomohiro
First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
-
Nakahara Yo
Applied Research Department The Chemo-sero-therapeutic Research Institute (kaketsuken)
-
Ushio Yoshitaka
Applied Research Department The Chemo-sero-therapeutic Research Institute (kaketsuken)
-
Sugawara Keishin
Applied Research Department The Chemo-sero-therapeutic Research Institute (kaketsuken)
-
Kamachi Yasuharu
Applied Research Department The Chemo-sero-therapeutic Research Institute (kaketsuken)
-
Imamura Takayuki
First Research Department The Chemo-sero-therapeutic Research Institute
-
Nozaki Chikateru
First Research Department
-
Yonemura Hiroshi
Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
-
Soejima Kenji
First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
-
Soejima Kenji
First Research Department
関連論文
- PJ-005 Localization of von Willebrand Factor-cleaving Protease (ADAMTS-13) in Coronary Thrombi from Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-3 (IHD) PJ1,Poster Session (Japanese),The 70th Anniversar
- OE-323 Functional Assay of von Willebrand Factor (VWF) and VWF-cleaving Protease (ADAMTS13) Activity in Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeti
- PJ-188 Changes in Plasma Von Willebrand Factor-cleaving Protease (ADAMTS13) Levels in Patients with Unstable Angina(Angina pectoris, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-179 Changes in Von Willebrand Factor-cleaving Protease (ADAMTS13) and Prognosis after Acute Myocardial Infarction(Thromboembolism/Antithrombotic therapy/Thrombolysis-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-157 Analysis of the Change of Von Willebrand Factor and ADAMTS13 Concentration following Radiofrequency Catheter Ablation of Atrial Fibrillation(PJ027,Arrhythmia, Others (Clinical/Pathophysiology) 2 (A),Poster Session (Japanese),The 73rd Annual Scienti
- Von Willebrand Factor-cleaving Protease (ADAMTS-13), a Novel Marker for Coronary Thrombosis in Acute Coronary Syndrome(Acute Coronary Syndrome, Basic/Clinical 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-684 Cilostazol Increases ADAMTS13 Expression in Endothelial Cells(PJ115,Thromboembolism/Antithrombotic Therapy/Thrombolysis (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 2 Von Willebrand Factor-cleaving Protease (ADAMTS13) as an Anti-thrombotic Marker in Acute Myocardial Infarction(New Evidence of Coronary Artery Disease-Pathogenesis, Diagnosis and Therapy, The 71st Annual Scientific Meeting of the Japanese Circulation So
- PJ-589 Serial Changes in von Willebrand Factor-cleaving Protease, ADAMTS-13 in Patients with Acute Myocardial Infarction(Acute myocardial infarction, clinical (pathophysiology)-4 (IHD) PJ99,Poster Session (Japanese),The 70th Anniversary Annual Scientific
- Preparation of Recombinant α-Thrombin : High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin
- A Novel Human Metalloprotease Synthesized in the Liver and Secreted into the Blood: Possibly, the von Willebrand Factor-Cleaving Protease?
- An Efficient Refolding Method for the Preparation of Recombinant Human Prethrombin-2 and Characterization of the Recombinant-Derived α-Thrombin
- Large-Scale Production of Major House Dust Mite Allergen Der f2 Mutant (C8/119S) in Escherichia coli(MEDICAL BIOTECHNOLOGY)
- A Convenient Method for Preparation of the Calcium Ion-Binding Protein Annexin V(MEDICAL BIOTECHNOLOGY)
- Preparation of Recombinant α-Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin